CIK: 0001560009
Total reported value
$141.4M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | CRSP | CRISPR Therapeutics AG | Stock-Healthcare | 50.00% | -0.16% | +17.73% | |
| 2 | VCYT | Veracyte INC | Stock-Other | 29.80% | — | — | |
| 3 | BOLDEUR | Audentes Therapeutics INC | Stock-Other | 10.32% | — | -33.33% | |
| 4 | CBAYUSD | Cymabay Therapeutics INC | Stock-Other | 4.76% | — | — | |
| 5 | OCUL | Ocular Therapeutix INC | Stock-Other | 2.90% | — | — | |
| 6 | ✓ | Second Sight Med Prods INC | Stock-Other | 1.18% | — | — | |
| 7 | CLVSEUR | Clovis Oncology INC | Stock-Other | 0.83% | — | — | |
| 8 | AKAOQ | Achaogen INC | Stock-Other | 0.19% | — | — | |
| 9 | ✓ | Opgen, Inc. | Stock-Other | 0.02% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | VCYT | Veracyte INC | +7.3% | — | Unchanged |
| 2 | CBAYUSD | Cymabay Therapeutics INC | +0.5% | — | Unchanged |
| 3 | ✓ | Opgen, Inc. | -0.1% | — | Unchanged |
| 4 | CLVSEUR | Clovis Oncology INC | -0.1% | — | Unchanged |
| 5 | AKAOQ | Achaogen INC | -0.6% | — | Unchanged |
| 6 | ✓ | Second Sight Med Prods INC | -0.8% | — | Unchanged |
| 7 | CRSP | CRISPR Therapeutics AG | -1% | +17.73% | Add |
| 8 | OCUL | Ocular Therapeutix INC | -1.5% | — | Unchanged |
| 9 | BOLDEUR | Audentes Therapeutics INC | -2.4% | -33.33% | Trim |
| 10 | IMRX | Immuneering Corporation | — | EXIT | Sold out |